Carl H. June
0000-0003-0241-3557
Publication & Citation Trends
Publications
0 total
CAR T therapy beyond cancer: the evolution of a living drug
Cited by 377
Semantic Scholar
Epitope base editing CD45 in hematopoietic cells enables universal blood cancer immune therapy OA
Cited by 88
Semantic Scholar
Ionizable Lipid Nanoparticles with Integrated Immune Checkpoint Inhibition for mRNA CAR T Cell Engineering OA
Cited by 82
Semantic Scholar
Immunotherapy: MULTIPLEX GENETIC ENGINEERING USING MICRORNA (MIRNA)-MEDIATED GENE SILENCING IN MESOTHELIN-DIRECTED CAR (M5CAR) T CELLS
Cited by 0
Semantic Scholar
Desmoplastic stroma restricts T cell extravasation and mediates immune exclusion and immunosuppression in solid tumors OA
Cited by 166
Semantic Scholar
Immunotherapy: GENETIC DISRUPTION OF IMMUNE REGULATORY RNA BINDING PROTEINS TO ENHANCE ADOPTIVE T CELL FUNCTION IN SOLID TUMORS
Cited by 0
Semantic Scholar
Publisher Correction: Potentiating adoptive cell therapy using synthetic IL-9 receptors OA
Cited by 2
Semantic Scholar
291 CAR T cells as a surgical adjuvant for unresectable adenocarcinoma OA
Cited by 0
Semantic Scholar
Research Topics
CAR-T cell therapy research
(946)
Immune Cell Function and Interaction
(357)
Immunotherapy and Immune Responses
(290)
Virus-based gene therapy research
(201)
T-cell and B-cell Immunology
(199)
Affiliations
University of Maryland, Baltimore
Henry M. Jackson Foundation
Novartis (Switzerland)
San Francisco General Hospital
National Institutes of Health